Teva's Judgment Bid Nixed In Pulmicort Case
A federal judge has rejected Teva Pharmaceutical Industries Ltd.'s summary judgment bid in AstraZeneca PLC's suit seeking to block Teva from launching a generic version of children's asthma drug Pulmicort Respules....To view the full article, register now.
Already a subscriber? Click here to view full article